Popular GLP-1 medicines used for weight loss and type 2 diabetes are facing growing legal scrutiny in the United States after more than 90 lawsuits alleged a connection between the drugs and a rare form of sudden vision loss. The lawsuits involve medications including Ozempic and Wegovy, made by Novo Nordisk, as well as other…